The global erectile dysfunction devices market is poised for significant growth, projected to expand from USD 1.7 billion in 2023 to USD 2.7 billion by 2028, at a CAGR of 8.8%, according to a comprehensive report by MarketsandMarkets™.

This substantial growth is primarily fueled by ongoing research and development in shockwave therapy and an increasing geriatric population, particularly affected by prostate cancer and related conditions.

In-Depth Market Analysis

The report, titled “Erectile Dysfunction Devices Market by Type (Vacuum Constriction Devices, Penile Implants), Source (Vascular, Neurologic Disorder), End-user (Hospital, Ambulatory Surgery Center), & Region (North America, Europe, Asia) – Global Forecast to 2028,” provides a detailed analysis of key market dynamics including drivers, opportunities, challenges, and restraints. It also outlines the strategies of leading players in the market, tracking their developments such as acquisitions, product launches, expansions, and partnerships.

Download PDF Brochure@

Key Findings:

Penile Implants Lead Market Share: In 2022, penile implants accounted for the largest share of the erectile dysfunction devices market. This segment’s dominance is attributed to the durability of implants and technological advancements that enhance their effectiveness and user satisfaction.

Vascular Disorders and Diabetes as Major Causes: Vascular disorders and diabetes were identified as the leading causes of erectile dysfunction in 2022. The increasing prevalence of diabetes and age-related cardiovascular diseases is expected to drive market growth during the forecast period.

Regional Insights: North America remains the largest market for erectile dysfunction devices, driven by a rising number of prostate cancer cases and the presence of numerous ambulatory surgery centers (ASCs). The Asia Pacific region follows as the second-largest market, bolstered by a growing elderly population and an increasing incidence of cardiovascular diseases.

Market Leaders:

Prominent players in the erectile dysfunction devices market include:

Boston Scientific Corporation (US)
Rigicon, Inc. (US)
Coloplast Group (Denmark)
Promedon GmbH (Argentina)
Zephyr Surgical Implants (Switzerland)

Different Growth Strategies Followed by Them:

These companies are at the forefront of innovation, continually enhancing their product offerings to meet the evolving needs of patients and healthcare providers.

Request Sample Pages@

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]